Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

about

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

Item

http://www.wikidata.org/entity/Q48347744

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@en

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@nl

type

Item

label

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@en

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@nl

prefLabel

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@en

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@nl

P1476

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.

@en

P2093

Gemma Currie

http://www.w3.org/2001/XMLSchema#string

Steven M Haffner

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Effect of valsartan on the incidence of diabetes and cardiovascular events

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.

Effect of ramipril on the incidence of diabetes.

Clinical practice. Nephropathy in patients with type 2 diabetes.

Preventing microalbuminuria in type 2 diabetes.

P304

791-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DOM.12877

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28093841

http://www.w3.org/2001/XMLSchema#string